GOSS vs JLL · rev $26.2M vs P/E 23, rev $13.31B
Gossamer Bio Inc (GOSS) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
GOSS currently screens at market cap $47.0M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the GOSS and JLL stock pages for the full models.
Not investment advice.